Prostate Cancer Treatments & The CTCA

In October 2015, the Administration Food and Drug Administration finally approved the high-intensity focused ultrasound (HIFU) to treat prostate cancer, nearly two decades after being approved by regulatory agencies in Asian countries and Europe.

doctors that the procedure, two hours, is minimally invasive say. Patients return home the same day and can continue with their normal activities. HIFU treatment may be partial, it focused on the overall tissue damage, or if the cancer is affecting the entire prostate.

Instead of using radiation, HIFU uses ultrasound energy to destroy the affected tissue. Ultrasound waves are directed to the area of prostate cancer that is then the temperature at the top of the probe insertion is increased to 90 degrees Celsius to destroy diseased tissue. The fabric in the outside of the injury remains intact.

In addition to skin cancer, prostate cancer is the most common type of cancer among men, with about 240,000 new cases reported each year, according to the American Cancer Society. At thee International HIFU Center in South Miami, the cost of treatment is $ 25,000. Suarez said that the likelihood of needing a second treatment is rare.

Prior to FDA approval, insurance companies usually do not cover the cost of treatment, claiming it was experimental. With FDA approval, insurance still do not cover, but may do so in the future due to certain criteria that the Cancer Treatment Centers of America has set in place for all effective methods of curing cancer. This condition may even permit holistic methods of eradicating cancer as well.

Of the 240,000 men are diagnosed annually with prostate cancer in the United States, a third party will select surgery. CTCA (Cancer Treatment Centers Of America) use 4D radiation therapy, immunotherapy and even hormone therapy to correct prostate cancer. For those that will select radiation CTCA has many other alternatives, some of which have been proven to be more effective.